Inhibitory Effect of Human Anti‐CA I Autoantibodies and Development of Monoclonal Antibody mAb 2B8 Targeting Carbonic Anhydrase I
Mediators of Inflammation · 2024
DOI: 10.1155/mi/9981131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, 2024. Verfasst von Petra Chalova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia. Hauptthemen laut MEDLINE: Autoantibodies, Carbonic Anhydrase I, Antibodies, Monoclonal. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstvo Školství, Mládeže a Tělovýchovy, Agentúra na Podporu Výskumu a Vývoja.
Abstract (Originalsprache)
Spontaneous tumor regression is a recognized phenomenon across various cancer types. Recent research emphasizes the alterations in autoantibodies against carbonic anhydrase I (CA I) (anti‐CA I) levels as potential prognostic markers for various malignancies. Particularly, autoantibodies targeting CA I and II appear to induce cellular damage by inhibiting their respective protein’s catalytic functions. Our study illuminates the profound impact of anti‐CA I autoantibodies from patient serum on the esterase activity of human CA I, exhibiting inhibitory effects akin to the acetazolamide inhibitor. Concurrently, our newly synthesized mouse monoclonal IgG antibody, mAb 2B8, against human CA I showcased a potent inhibitory action. An in‐depth exploration into mAb 2B8′s binding dynamics with its target enzyme was undertaken. Leveraging epitope extraction and phage display library techniques, we identified the amino acid sequence DFWTYP (positions 191–196 of CA I) as crucial for mAb 2B8′s interaction. In 3‐D structural analysis, this sequence is spatially adjacent to a previously identified epitope (DFWTYP) that interacts with patient‐derived autoantibodies. Critically, mAb 2B8 demonstrated an ability to infiltrate eukaryotic cells, engaging specifically with its intracytoplasmic target. This positions mAb 2B8 as a promising model for future studies aimed at tumor cell eradication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
- Department of Pharmaceutical Analysis and Nuclear Pharmacy, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia.
- Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Pardubice, Czech Republic.
- Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
- Institute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovakia.
- Institute of Normal and Pathological Physiology, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia.
ORCID-Profile: Eliska Zelinkova, Zuzana Bilkova, Marcela Slovakova, Lucie Korecka, Petr Muller, Maksym Danchenko, Lenka Minichova, Jan Lakota, Ludovit Skultety
Förderung
- Ministerstvo Školství, Mládeže a Tělovýchovy
- Agentúra na Podporu Výskumu a Vývoja
Zitieren
APA
Chalova, P., Jankovicova, B., Dvorakova, V., Zelinkova, E., Bilkova, Z., Slovakova, M., Korecka, L., Muller, P., Danchenko, M., Minichova, L., Lakota, J., & Skultety, L. (2024). Inhibitory Effect of Human Anti‐CA I Autoantibodies and Development of Monoclonal Antibody mAb 2B8 Targeting Carbonic Anhydrase I. Mediators of Inflammation. https://doi.org/10.1155/mi/9981131
Vancouver
Chalova P, Jankovicova B, Dvorakova V, Zelinkova E, Bilkova Z, Slovakova M, et al. Inhibitory Effect of Human Anti‐CA I Autoantibodies and Development of Monoclonal Antibody mAb 2B8 Targeting Carbonic Anhydrase I. Mediators of Inflammation. 2024. doi:10.1155/mi/9981131
BibTeX
@article{Chalova2024,
author = {Chalova, Petra and Jankovicova, Barbora and Dvorakova, Veronika and Zelinkova, Eliska and Bilkova, Zuzana and Slovakova, Marcela and Korecka, Lucie and Muller, Petr and Danchenko, Maksym and Minichova, Lenka and Lakota, Jan and Skultety, Ludovit},
title = {Inhibitory Effect of Human Anti‐CA I Autoantibodies and Development of Monoclonal Antibody mAb 2B8 Targeting Carbonic Anhydrase I},
journal = {Mediators of Inflammation},
year = {2024},
doi = {10.1155/mi/9981131}
}
EUVIMED